nach oben

Journal of Neuro-Oncology

Erschienen in:

01.03.2008 | Lab. Investigation-human/animal tissue

Slit2 involvement in glioma cell migration is mediated by Robo1 receptor

verfasst von: Sonja Mertsch, Nicole Schmitz, Astrid Jeibmann, Jian-Guo Geng, Werner Paulus, Volker Senner

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Slit and Robo proteins are evolutionarily conserved molecules whose interaction underlies axon guidance and neuronal precursor cell migration. During development secreted Slit proteins mediate chemorepulsive signals on cells expressing Robo receptors. Because similar molecular mechanisms may be utilized in glioma cell invasion and neuroblast migration, we studied the expression of Slit2 and its transmembrane receptor Robo1 as well as their functional role in migration in glioma cells. qRT-PCR and immunohistochemistry of human specimens revealed that Slit2 was distinctly expressed by non-neoplastic neurons, but at only very low levels in fibrillary astrocytoma and glioblastoma. Robo1 also was mainly restricted to neurons in the normal brain, whereas astrocytic tumor cells in situ as well as glioblastoma cell lines overexpressed Robo1 at mRNA and protein levels. Recombinant human Slit2 in a concentration of 0.45 nM was repulsive for glioma cell lines in a modified Boyden chamber assay. RNAi-mediated knockdown of Robo1 in glioma cell lines neutralized the repulsive effect of Slit2, demonstrating that Robo1 served as the major Slit2 receptor. Our findings suggest that a chemorepulsive effect mediated by interaction of Slit2 and Robo1 participates in glioma cell guidance in the brain.

Wong K, Park HT, Wu JY, Rao Y (2002) Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. Curr Opin Genet Dev 12:583–591PubMedCrossRef

Dickson BJ, Gilestro GF (2006) Regulation of commissural axon pathfinding by slit and its Robo receptors. Annu Rev Cell Dev Biol 22:651–675PubMedCrossRef

Erskine L, Williams SE, Brose K et al (2000) Retinal ganglion cell axon guidance in the mouse optic chiasm: expression and function of Robos and Slits. J Neurosci 20:4975–4982PubMed

Hammond R, Vivancos V, Naeem A, Chilton J et al (2005) Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. Development 132:4483–4495PubMedCrossRef

Mambetisaeva ET, Andrews W, Camurri L, Annan A, Sundaresan V (2005) Robo family of proteins exhibit differential expression in mouse spinal cord and Robo–Slit interaction is required for midline crossing in vertebrate spinal cord. Dev Dyn 233:41–51PubMedCrossRef

Fouquet C, Di Meglio T, Ma L et al (2007) Robo1 and robo2 control the development of the lateral olfactory tract. J Neurosci 27:3037–3045PubMedCrossRef

Wang KH, Brose K, Arnott D et al (1999) Biochemical purification of a mammalian Slit protein as a positive regulator of sensory axon elongation and branching. Cell 96:771–784PubMedCrossRef

Whitford KL, Marillat V, Stein E et al (2002) Regulation of cortical dendrite development by Slit–Robo interactions. Neuron 33:47–61PubMedCrossRef

Ward M, McCann C, DeWulf M, Wu JY, Rao Y (2003) Distinguishing between directional guidance and motility regulation in neuronal migration. J Neurosci 23:5170–5177PubMed

10.

Sawamoto K, Wichterle H, Gonzalez-Perez O et al (2006) A. New neurons follow the flow of cerebrospinal fluid in the adult brain. Science 311:629–632PubMedCrossRef

11.

Nguyen-Ba-Charvet KT, Picard-Riera N, Tessier-Lavigne M, Baron-Van Evercooren A, Sotelo C, Chedotal A (2004) Multiple roles for slits in the control of cell migration in the rostral migratory stream. J Neurosci 24:1497–1506PubMedCrossRef

12.

Wu JY, Feng L, Park HT et al (2001) The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 410:948–952PubMedCrossRef

13.

Guan H, Zu G, Xie Y et al (2003) Neuronal repellent Slit2 inhibits dendritic cell migration and the development of immune responses. J Immunol 171:6519–6526PubMed

14.

Liu D, Hou J, Hu X et al (2006) Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation. Circ Res 98:480–489PubMedCrossRef

15.

Schmid BC, Rezniczek GA, Fabjani G, Yoneda T, Leodolter S, Zeillinger R (2007) The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells. Breast Cancer Res Treat [PMID: 17268810]

16.

Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109PubMedCrossRef

17.

Claes A, Idema AJ, Wesseling P (2007) Diffuse glioma growth: a guerilla war. Acta Neuropathol 114:443–458PubMedCrossRef

18.

Werbowetski T, Bjerkvig R, Del Maestro RF (2004) Evidence for a secreted chemorepellent that directs glioma cell invasion. J Neurobiol 60:71–88PubMedCrossRef

19.

Suzuki SO, McKenney RJ, Mawatari SY et al (2007) Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferation. Acta Neuropathol 113:591–599PubMedCrossRef

20.

Senner V, Kismann E, Püttmann S, Hoess N, Baur I, Paulus W (2002) L1 expressed by glioma cells promotes adhesion but not migration. Glia 38:146–154PubMedCrossRef

21.

Werbowetski-Ogilvie TE, Seyed Sadr M, Jabado N et al (2006) Inhibition of medulloblastoma cell invasion by Slit. Oncogene 25:5103–5112PubMed

22.

Dallol A, Krex D, Hesson L, Eng C, Maher ER, Latif F (2003) Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 22:4611–4616PubMedCrossRef

23.

Dallol A, Morton D, Maher ER, Latif F (2003) SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer 63:1054–1058

24.

Narayan G, Goparaju C, Arias-Pulido H et al (2006) Promoter hypermethylation-mediated inactivation of multiple Slit–Robo pathway genes in cervical cancer progression. Mol Cancer 5:16PubMedCrossRef

25.

Astuti D, Da Silva NF, Dallol A et al (2004) SLIT2 promoter methylation analysis in neuroblastoma, Wilms’ tumour and renal cell carcinoma. Br J Cancer 90:515–521PubMedCrossRef

26.

Rossi MR, Huntoon K, Cowell JK (2005) Differential expression of the LGI and SLIT families of genes in human cancer cells. Gene 356:85–90PubMedCrossRef

27.

Xian J, Aitchison A, Bobrow L et al (2004) Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter. Cancer Res 64:6432–6437PubMedCrossRef

28.

Prasad A, Fernandis AZ, Rao Y, Ganju RK (2004) Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. J Biol Chem 279:9115–9124PubMedCrossRef

29.

Marillat V, Cases O, Nguyen-Ba-Charvet KT, Tessier-Lavigne M, Sotelo C, Chedotal A (2002) Spatiotemporal expression patterns of slit and robo genes in the rat brain. J Comp Neurol 442:130–155PubMedCrossRef

Titel: Slit2 involvement in glioma cell migration is mediated by Robo1 receptor
verfasst von: Sonja Mertsch
Nicole Schmitz
Astrid Jeibmann
Jian-Guo Geng
Werner Paulus
Volker Senner
Publikationsdatum: 01.03.2008
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 1/2008
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-007-9484-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study

A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases

Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India

The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms

HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration

A case of atypical thyrotroph cell adenoma, which re-grew within 3 months after surgery and required multimodal treatment